Angeles Wealth Management’s Bio-Techne TECH Stock Holding History

Angeles Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$370K	Buy	7,080 +550	+8%	+$33K	0.02%	283
2025 Q4	$384K	Buy	6,530 +827	+15%	+$50.3K	0.02%	251
2025 Q3	$317K	Buy	5,703 +189	+3%	+$10.1K	0.02%	248
2025 Q2	$284K	Buy	5,514 +1,464	+36%	+$73.6K	0.02%	272
2025 Q1	$237K	Buy	4,050 +13	+0.3%	+$881	0.02%	258
2024 Q4	$291K	Buy	4,037 +85	+2%	+$6.24K	0.02%	219
2024 Q3	$316K	Buy	+3,952	New	+$297K	0.03%	192

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Angeles Wealth Management's TECH Position: Q1 2026 in Review

Angeles Wealth Management increased its Bio-Techne (TECH) stake by 8.4% in Q1 2026, buying an estimated $33K and bringing the position to 7,080 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #283.

Angeles Wealth Management first reported a position in TECH in Q3 2024 and has held it in 7 quarters since. The position peaked at $384K in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Angeles Wealth Management held 7,080 shares of Bio-Techne worth $370K as of Q1 2026.
Angeles Wealth Management bought 550 Bio-Techne shares in Q1 2026, an estimated $33K.
Bio-Techne made up 0.02% of Angeles Wealth Management's portfolio in Q1 2026, its #283 holding.
Angeles Wealth Management first reported a position in Bio-Techne in Q3 2024 and has held it in 7 quarters since.
Angeles Wealth Management's Bio-Techne position peaked at $384K in Q4 2025.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.